Clinical and molecular characteristics of simple virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: insight from a tertiary pediatric center in Vietnam
Authors:
Open Access
- 31 December 2025
- journal article
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 30 (6) , 330-339
Abstract
Purpose: Simple virilizing congenital adrenal hyperplasia (SV-CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disease caused by pathogenic variants of the CYP21A2 gene. Children with SV-CAH often experience delayed diagnosis, presenting with pseudo-precocious puberty in males and genital virilization in females. Genotyping is essential for diagnosis, treatment, optimization, and phenotype prediction. This study describes the clinical and genetic characteristics of SV-CAH to guide treatment strategies.Methods: From November 2016 to March 2023, 79 children (accounting for 34.3% of 230 CAH cases in the overall children’s cohort) from 75 families were classified as SV-CAH due to 21-OHD at the Vietnam National Children's Hospital. Forty-three children underwent CYP21A2 mutation analysis using multiplex ligation-dependent probe amplification and complete gene sequencing to detect pathogenic variants.Results: Median age at diagnosis was 4.5 years (interquartile range, 1 day–22.3 years). There were 38.0% males and 62.0% females. The most common symptoms were penile enlargement in males (53.3%) and clitoromegaly (87.8%) in females; the height standard deviation (SD) at diagnosis was 1.90±1.79 SD (-2.02 to 5.43) according to the World Health Organization; and bone age advancement was 4.65±2.59 years. Genetic analysis identified 21 pathogenic variants and 22 genotypes in 43 children. The most common variant was p.I173N (47.7%); the most common genotype was p.I173N/p.I173N (16.3%).Conclusion: Children with SV-CAH are often diagnosed late. To avoid that, early genetic analysis should be prioritized, especially for children diagnosed through newborn screening programs. Determining the genotype is crucial for optimizing treatment strategies, ensuring personalized management, and avoiding overtreatment.Keywords
This publication has 31 references indexed in Scilit:
- CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa RicaMolecular Genetics and Metabolism Reports, 2021
- Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern ChinaSteroids, 2019
- Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasiaMolecular Genetics & Genomic Medicine, 2019
- Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screeningJournal of the Formosan Medical Association, 2017
- The next 150 years of congenital adrenal hyperplasiaThe Journal of Steroid Biochemistry and Molecular Biology, 2015
- Structure–phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasiaProceedings of the National Academy of Sciences, 2013
- Clinical Characteristics of Taiwanese Children With Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency in the Pre-screening EraJournal of the Formosan Medical Association, 2010
- Genetics of congenital adrenal hyperplasiaBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHuman Reproduction Update, 2004
- Early growth is not increased in untreated moderately severe 21‐hydroxylase deficiencyActa Paediatrica, 1995